The experts tend to downplay the impact of stock splits, but that doesn't seem to quell investor giddiness when, say, one share turns into seven.
Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
An employee beneath a carriage of a London Underground Northern Line train at Alstom SA's Traincare Centre in London. Photographer: Chris Ratcliffe/Bloomberg.
Stocks snapped their recent winning streak Wednesday, as weakness in technology shares weighed on equity indexes. The Dow Jones Industrial Average shed 12.72 points, or 0.1%, to 16501.65.
Demand from homebuyers continues to outpace supply, according to new housing numbers released yesterday, and experts said relief from rising prices and low inventory isn't in sight anytime soon.